ZTS Stock: Price, Earnings History and SEC Filings
Zoetis Inc. (ZTS) last traded at $79.72, up 1.17% on the latest session and up 14.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.87 against an analyst estimate of $1.84, a beat of 1.6%.
$79.72 +1.17%
1 month+14.16%
52-week high$144.83
52-week low$68.77
Volume4.12M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ZTS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $1.87 | $1.84 | +1.63% |
| Mar 2026 | May 7, 2026 | $1.53 | $1.61 | -4.97% |
| Dec 2025 | Feb 12, 2026 | $1.48 | $1.40 | +5.71% |
| Sep 2025 | Nov 4, 2025 | $1.70 | $1.62 | +4.94% |
ZTS beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ZTS
SEC filing data is not available right now. You can search for ZTS on SEC EDGAR.
ZTS news
- Zoetis stock trades at EUR 71.24 ahead of Q3 resultsNov 1, 2026 · ad-hoc-news.de
- IDEXX Laboratories Reports Soon: How Has The Stock Reacted To Past Earnings?Oct 30, 2026 · trefis.com
- Zoetis (ZTS) Ascends While Market Falls: Some Facts to NoteOct 29, 2026 · finance.yahoo.com
- Michael Burry Portfolio: Top 5 Stock PicksOct 29, 2026 · finance.yahoo.com
- Zoetis (ZTS) vs. IDXX and ELAN: Is Valuation Compression Creating a Rare Opportunity in Animal Health?Oct 29, 2026 · finance.yahoo.com
- Zoetis (ZTS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseOct 29, 2026 · finance.yahoo.com
- Zoetis (ZTS) Wins FDA Approval For Convenia RTU, Is The Undervaluation Case Still Intact?Oct 29, 2026 · finance.yahoo.com
- FDA approves Convenia RTU ahead of Q3 results for Zoetis stockOct 29, 2026 · ad-hoc-news.de
About Zoetis Inc.
Zoetis Inc. (ZTS) is a US-listed public company on NYSE.